Holen Sie sich die Stockscreener-App
3.43
5.77%
-0.21
Handel nachbörslich:
3.49
0.06
+1.75%
Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - |
Operating Expenses
|
11.45%
1.3011
|
1.4693 | 2.2309 | 2.7805 |
| Depreciation and Amortization |
32.13%
0.00936
|
0.0138 | 0.00869 | 0.0153 |
| Operating Income/Loss |
11.45%
-1.3011
|
-1.4693 | -2.2309 | -2.7805 |
| Income/Loss From Continuing Operations Before Tax |
18.29%
-1.2259
|
-1.0363 | -2.2292 | -2.7757 |
| Income Tax Expense/Benefit |
-
|
- | - | - |
| Income/Loss From Continuing Operations After Tax |
18.29%
-1.2259
|
-1.0363 | -2.2292 | -2.7757 |
|
Net Income/Loss
|
18.29%
-1.2259
|
-1.0363 | -2.2292 | 2.7757 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | 5.5514 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - |
2.14%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):